Kura Oncology, Inc.KURANASDAQ
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank100
Studio
Year-over-Year Change

Enterprise value to sales ratio

Latest
11.59
↑ 435% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthElevated
Average
2.17
Historical baseline
PeriodValueYoY Change
202511.59+15.1%
202410.07-
20230.00-
20220.00-
20210.00-
20200.00-
20190.00-
20180.00-
20170.00-
20160.00-